T/SATA 094-2025 Standard
Carewells co-authored Asia's dysphagia food standard as Participating Drafting Unit (September 2025). The 18–24 month compliance window for GBA care-home procurement opens now.
US$3M Seed Round · Carewells Limited
Building Asia's Integrated Dysphagia-Care Platform
Food + Software + Hardware + Community — one data layer, one AI stack, one defensible bundle no single-layer competitor can replicate.
Founding Team Track Record
Carewells's founding team brings 10+ years of experience in food technology and dysphagia care, with postgraduate degrees in food science, clinical nutrition, and biomedical engineering. Entrepreneurial journey is the subject of a Harvard Business Publishing teaching case (W33928) and Ivey Business School MBA curriculum publication. Co-author of T/SATA 094-2025 GBA dysphagia food standard. HKSTP incubatee. Carewells operates from HK Science Park with R&D collaboration at HKUST Shenzhen Research Institute and HKU.
Investment Thesis
Care food is becoming infrastructure. T/SATA 094-2025 (September 2025) creates a compliance window for GBA care homes and hospitals — incumbent food brands lack the standards-body authorship; pure-tech entrants lack the IDDSI manufacturing know-how. Carewells co-authored the standard, ships the products, and is building the AI assessment hardware (LinguaLeap, TechUP-funded) that makes IDDSI level prescription data-driven. The next 18 months are the window where standards-led incumbency compounds. We are raising US$3M to lock that window.
Traction
Current trailing-12-month revenue: figure available in data room — request access via investors@seniordeli.com
- Care homes & hospitals served (HK)
- 200+
- WeChat private-pool members
- 12,836+
- Patents held
- 7
- International awards
- 17+
- TechUP grant (LinguaLeap, Dec 2025)
- HKD 600K
- Future Food Asia 2021 award
- US$100K
Why Now
Japan Reimbursement
Japan's 嚥下調整食 fee revision went live April 2026 — hospitals now have a billing incentive to procure JSDR-2021-compliant products.
China 长护险 National Rollout
China's Long-Term Care Insurance went national September 2025. 310M people aged 60+ represents the largest addressable market for dysphagia food compliance tools globally.
Why the Bundle Is the Moat
A pure-food competitor (Nestlé Health Science, Abbott) has product but no workflow software, no hardware, no Cantonese interface, no standards seat. A pure-hardware competitor (ElliQ, Hyodol) has device but no clinical food product, no IDDSI compliance, no GBA standards. Carewells has all five layers.
- ✓IDDSI-compliant food (SeniorDeli)
- ✓T/SATA 094-2025 standard authorship
- ✓WeChat 12,836+ member community
- ✓B2B nurse/care-home dashboard
- ✓LinguaLeap AI assessment hardware
The Raise
US$3M Seed
US$15M pre-money valuation (post-money US$18M)
18-Month Milestones: 30 care homes on dashboard · HK$8M ARR · Japan pilot signed · IDDSI lab application submitted
For information only — not a securities offer. Carewells Limited HK incorporation in progress. This page does not constitute an offer to sell or solicitation to buy securities in any jurisdiction.
Use of Proceeds
- 40%Engineering (dashboard + LinguaLeap)
- 25%Sales & GTM (HK + Japan)
- 20%IDDSI lab + standards
- 15%Working capital
Recognition & Credentials
- Future Food Asia 2021 Award — US$100,000
- HKSEC Champion
- Harvard Business Publishing teaching case (W33928) — subject
- TechUP Y06 Grant Recipient — HKD 600,000 (December 2025)
- T/SATA 094-2025 Participating Drafting Unit (September 2025)
- HKSTP Incubatee
Why This Team · Why This Stage
9 years operating
Incorporated 2013. Survived and scaled through COVID, GBA lockdowns, and a care-home procurement freeze. HKD 20M+ annual revenue. This is a proven operating team, not a first-time pre-revenue bet.
HKSTP + HKUST + HKU partnerships
HKSTP incubatee. Active HKU industry-academia-research collaboration. HKUST Shenzhen Research Institute partnership. Access to clinical validation infrastructure and academic distribution channels.
Standards-body recognition — rare for a startup
Participating Drafting Unit of T/SATA 094-2025 (Greater Bay Area dysphagia food standard). This is not a certification — it is a standards-authorship seat, which creates procurement mandates for the 18–24 month compliance window now opening across GBA care homes.
Patent portfolio + R&D base
7 proprietary invention patents in care food processing technology. Active R&D pipeline: LinguaLeap AI swallowing assessment (TechUP-funded HKD 600K, Dec 2025).
International recognition
Harvard Business Publishing teaching case W33928. Ivey Business School MBA curriculum. Future Food Asia 2021 Champion (Singapore, US$100K prize). Covered by SCMP, NutraIngredients-Asia, FoodNavigator-Asia, CompassList, Eco-Business, Yomiuri Shimbun.
Roadmap to Series A
- ·
2026
Dashboard MVP ships; 30+ HK B2B contracts; Mainland CBEC live; Japan HCR booth
- ·
2027
T/SATA 094 revision committee chair; HKMD Class I cleared; FDA Breakthrough Device program — application in preparation; Series A
- ·
2028
FDA cleared; CE marking; Japan distribution at scale; SEA expansion
- ·
2029-30
Strategic exit conversations: Nestlé Health Science / Meiji / Kewpie / SoftBank / Sony
Investor FAQ
- What is the legal entity status?
- Carewells Limited is incorporating in Hong Kong (process initiated 2026, expected completion Q3 2026). Until incorporation completes, the founding team accepts non-binding LOIs and will sign definitive documents post-incorporation. Pre-incorporation due diligence questions are welcomed via investors@seniordeli.com.
- What is Carewells Limited?
- Carewells Limited is the holding company operating SeniorDeli (dysphagia food brand), the WeChat community (12,836+ members), and the B2B care-home dashboard. SeniorDeli is partnering with tech startup LinguaLeap on AI swallowing assessment hardware. HK incorporation in progress.
- What is T/SATA 094-2025?
- T/SATA 094-2025 is the group standard for dysphagia food (care for elderly) published September 2025. Carewells is a Participating Drafting Unit — meaning we co-authored the compliance bar our competitors must now meet.
- What is the exit strategy?
- Strategic sale to Nestlé Health Science, Meiji, Kewpie, SoftBank, or Sony in 2029-30. The bundle — food + software + hardware + data — is the strategic prize.
- How do I access the data room?
- Email investors@seniordeli.com with your name, fund, and AUM. We will respond within 2 business days with a secure data room link.
Product Traction
4+
Care homes in pilot
50+
Clinical assessments logged
Free
Funded by product sales
Get in Touch
Data room available on request to verified investors.
This page is for informational purposes only and does not constitute an offer or solicitation of securities. Carewells Limited (BR pending). All figures are management estimates as of May 2026.